AST Quote, Trading Chart, Asterias Biotherapeutics Inc. Common Series A

$ Last:

0.00% Change Percent:

$N/A Open:

$0.945 Previous Close:

$N/A High:

$N/A Low:

0 Volume:

01/01/1970 12:00:00 am Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Stock Date	Open Price	Close Price	High	Low	Volume
2019-03-11	N/A	0.945	N/A	N/A	0
2019-03-08	N/A	0.945	N/A	N/A	0
2019-03-07	0.9299	0.945	0.948	0.90	99,201
2019-03-06	0.91	0.95	0.95	0.865	63,940
2019-03-05	0.88	0.89	0.89	0.85	116,626
2019-03-04	0.95	0.87	0.9534	0.85	174,358
2019-03-01	0.92	0.95	0.9723	0.91	60,370
2019-02-28	0.97	0.91	0.9794	0.91	69,020
2019-02-27	0.9565	0.98	0.98	0.95	36,925
2019-02-26	0.9599	0.97	1.00	0.92	78,759
2019-02-25	0.94	0.9415	0.988	0.91	102,965
2019-02-22	0.941	0.93	0.941	0.92	24,119
2019-02-21	0.9406	0.93	0.95	0.92	52,722
2019-02-20	0.97	0.923	0.97925	0.92	67,684
2019-02-19	0.9171	0.96	0.96	0.9037	47,500
2019-02-18	0.90	0.89	0.92	0.878	88,663
2019-02-15	0.90	0.89	0.92	0.878	88,663
2019-02-14	0.91	0.88	0.9146	0.8701	66,686
2019-02-13	0.88	0.8892	0.899206	0.8701	33,012
2019-02-12	0.90	0.87	0.90	0.822	150,334

Stock Information

Asterias Biotherapeutics Inc. Common Series A Company Name:

AST Stock Symbol:

NYSE Market:

Get AST Alerts

News, Short Squeeze, Breakout and More Instantly...

AST - Asterias Provides Top Line 12 Month Data Update for its OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury

FREMONT, Calif., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated with demyelination and cellular immunotherapies to treat cancer, today ...